EFNA3 is a prognostic biomarker for the overall survival of hepatocellular carcinoma patients. Lin P, Yang H. J Hepatol 2022 Mar 28. pii: S0168-8278(22)00176.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lin P, Yang H. EFNA3 is a prognostic biomarker for the overall survival of hepatocellular carcinoma patients. J Hepatol 2022 Mar 28. pii: S0168-8278(22)00176.
PMID: 35358615